Tumor heterogeneity as a rationale for a multiepitope approach in an autologous renal cell cancer tumor vaccine.

Autor: Wittke, Stefan1 swittke@hs-bremerhaven.de, Baxmann, Susann2, Fahlenkamp, Dirk3, Kiessig, Stephan T.2
Zdroj: OncoTargets & Therapy. Jan2016, Vol. 9, p523-537. 15p.
Databáze: Academic Search Ultimate